Self Mobility Improvement in the Elderly by Counteracting Falls (SMILING)
NCT ID: NCT00877721
Last Updated: 2010-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2010-04-30
2010-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The proposed project is a prospective experimental study design. Independent old adults (age 65 years old and older) who suffer from minor balance problems willing to participate in the study will be tested with well-established measuring techniques of balance and gait before and 4 weeks after balance training program using the "Self Mobility Improvement in the Elderly by Counteracting Falls" system (SMILING system). The study design is randomized clinical trial (RCT), cross over, single blinded study design where 30 subjects will randomly be allocated into experimental or control groups that will switch groups after 4 weeks of intervention.
Random sequence generation will be performed by a staff member who will not interact with subjects during the balance-testing sessions. Subjects will be informed that they are to be randomly assigned to one of the two groups, both receiving gait training program.
The staff member who administers the training programs will be the only member of the research team aware of the subjects' group allocations.
A 'blinded' research assistant will administer the balance tests and will perform any data processing that involves subjective judgments.
Scripts will be used during testing to ensure that all subjects receive the same instructions.
Testing session between two training periods (T1) will take one week.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
balance treatment
Self Mobility Improvement in the eLderly by using the SMILING system
The effect of treatment with the SMILING system on postural stability and gait of elderly individuals will be measured using RCT cross over study design
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Self Mobility Improvement in the eLderly by using the SMILING system
The effect of treatment with the SMILING system on postural stability and gait of elderly individuals will be measured using RCT cross over study design
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. age ≥ 65 years,
2. able to walk at least 20 meters independently, i.e., without personal assistance and without an assistive device, except for a single point cane
3. one or more falls in the previous year (falls during sport activities excluded).
Standardized physical and cognitive functional tests
1. Tinetti's POMA score below 26 (strictly)
2. MMSE test with score ≥ 24
3. GDS test with score \<10
Exclusion Criteria
2. age \< 65 years
3. inability to walk 20 meters safely (self-report) or walk with personal assistance or with an assistive device (except single point cane for fallers)
4. inability to recall fall status in the previous year
5. severe visual impairment (e.g., impaired ability to read, watch TV, or drive a car)
6. severe hearing impairment (e.g., unable to follow a conversation, to use a phone)
7. Standardized physical and cognitive functional tests
8. Tinetti's POMA score less than 19
9. MMSE score \< 24
10. GDS test with score ≥ 10
11. Medical conditions (filled in by the family doctor of the subject)
12. wearing a pacemaker, a cardiac defibrillator or any other electronic implant
13. severe gait impairment precluding safe walking over 20 meters due to:
14. focal lower limb muscle weakness or palsy (e.g., unable to raise leg/foot from floor)
15. neurological diseases, including diseases such as severe Parkinson's disease, Multiple Sclerosis, status post stroke with hemi-syndroma, cervical or lumbar stenosis with compression myelopathy, polyneuropathy with severe proprioceptive impairment, Menier
16. severe cardiovascular disease
17. foot problems, lower limb amputation or joint arthrodesis
18. terminal diseases (defined as estimated life expectancy of less than 6 months).
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Union
OTHER
Soroka University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ben-Gurion University of the Negev
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yakov Grinshpon, MD
Role: STUDY_CHAIR
Soroka University Medical Center
Itshak Melzer, PhD
Role: PRINCIPAL_INVESTIGATOR
Ben-Gurion University of the Negev
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SorokaUMC
Beersheba, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MZ4832
Identifier Type: -
Identifier Source: secondary_id
SOR483209CTIL
Identifier Type: -
Identifier Source: org_study_id